Global Financial Private Client, LLC Abb Vie Inc. Transaction History

Global Financial Private Client, LLC

$257 Billion
Q3 2024

A detailed history of Global Financial Private Client, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 2,723 shares of ABBV stock, worth $461,902. This represents 0.21% of its overall portfolio holdings.

Number of Shares

2,723

Previous 2,527 7.76%

Holding current value

$461,902

Previous $434 Million 24.03%

% of portfolio

0.21%

Previous 0.18%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$163.84 - $199.33 $32,112 - $39,068	196 Added 7.76%	2,723 $538 Million
Q2 2024 Jul 29, 2024	BUY	$154.79 - $180.76 $154 - $180	1 Added 0.04%	2,527 $434 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $639 - $728	4 Added 0.16%	2,526 $457 Million
Q4 2023 May 15, 2024	SELL	$137.6 - $154.97 $45,132 - $50,830	-328 Reduced 11.51%	2,522 $391 Million
Q3 2023 May 15, 2024	BUY	$133.59 - $154.65 $267 - $309	2 Added 0.07%	2,850 $423 Million
Q2 2023 May 15, 2024	SELL	$132.51 - $164.9 $155,699 - $193,757	-1,175 Reduced 29.21%	2,848 $385 Million
Q1 2023 May 15, 2024	BUY	$144.61 - $166.54 $144 - $166	1 Added 0.02%	4,023 $645 Million
Q4 2022 May 15, 2024	BUY	$138.31 - $165.87 $48,131 - $57,722	348 Added 9.47%	4,022 $650 Million
Q3 2022 May 15, 2024	BUY	$134.21 - $153.93 $34,894 - $40,021	260 Added 7.62%	3,674 $508 Million
Q2 2022 May 15, 2024	BUY	$137.62 - $174.96 $28,762 - $36,566	209 Added 6.52%	3,414 $525 Million
Q1 2022 May 15, 2024	BUY	$131.98 - $163.75 $104,660 - $129,853	793 Added 32.88%	3,205 $521 Million
Q4 2021 May 15, 2024	BUY	$107.43 - $135.93 $24,816 - $31,399	231 Added 10.59%	2,412 $327 Million
Q3 2021 May 15, 2024	BUY	$106.4 - $120.78 $212 - $241	2 Added 0.09%	2,181 $238 Million
Q2 2021 May 15, 2024	BUY	$105.21 - $117.21 $105 - $117	1 Added 0.05%	2,179 $249 Million
Q1 2021 May 15, 2024	SELL	$102.3 - $112.62 $1,739 - $1,914	-17 Reduced 0.77%	2,178 $236 Million
Q4 2020 May 15, 2024	BUY	$80.49 - $108.67 $1,770 - $2,390	22 Added 1.01%	2,195 $235 Million
Q3 2020 May 15, 2024	SELL	$85.91 - $100.83 $34,020 - $39,928	-396 Reduced 15.41%	2,173 $189 Million
Q2 2020 May 15, 2024	SELL	$73.37 - $98.18 $12,032 - $16,101	-164 Reduced 6.0%	2,569 $255 Million
Q4 2019 May 15, 2024	BUY	$72.13 - $90.25 $197,131 - $246,653	2,733 New	2,733 $242 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Financial Private Client, LLC with notifications on news.

Account

Global Financial Private Client, LLC Abb Vie Inc. Transaction History